Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.

Topic

March 27, 2017

First patent opposition MSF has filed in Europe aims to increase affordable access to hepatitis C drug sofosbuvir for millions

NEW YORK/ROME/GENEVA, MARCH 27, 2017—In an effort to increase access to affordable hepatitis C treatment, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) filed a patent challenge on the lifesaving hepatitis C drug sofosbuvir with the European Patent Office (EPO) today.

February 14, 2017

NEW YORK/NEW DELHI, FEBRUARY 14, 2017—Five new challenges against flawed patents on crucial new medicines to treat hepatitis C filed in India and Argentina are the latest in a global push to ensure access to affordable treatment. The patent challenges could remove barriers to production and distribution of affordable generic versions of direct-acting antiviral (DAA) medicines, including sofosbuvir, daclatasvir and velpatasvir, and increase access for millions of people.

February 08, 2017

NEW YORK/N’AJAMENA, CHAD, FEBRUARY 9, 2017—A hepatitis E outbreak is escalating across Am Timan, in the Salamat region of South-Eastern Chad, and more humanitarian actors are urgently needed to treat patients and contain further spread of the virus, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) said today.

January 25, 2017

NEW YORK, JANUARY 25, 2017—The reinstatement of the US government’s Mexico City Policy by President Donald J. Trump, which prohibits nongovernmental organizations that receive US funding from either performing or providing counseling or information on abortion, will undermine access to safe abortion services and endanger the lives of women, said Doctors Without Borders/Médecins Sans Frontières (MSF) Wednesday.

September 16, 2016

"The sustainable development goals (SDGs) adopted with much fanfare just a year ago seek to end HIV, tuberculosis, and malaria by 2030. The replenishment of the Global Fund is the first concrete action taken by the international community since the adoption of these goals, and therefore a first test of the world leaders' will to make them a reality. Failure to reach the relatively modest Global Fund's replenishment target would be a clear message that the SDGs were but empty promises to the millions who, every year, continue to suffer and die from HIV, tuberculosis, and malaria."

September 14, 2016

New report exposes pharmaceutical industry failings and highlights new ways of researching and developing medicines that address public health needs.

July 21, 2016

Trade agreements and pressure on India’s ‘pharmacy of the developing world’ pose major threats to access

July 20, 2016

PARIS/NEW YORK—A humanitarian catastrophe is underway in northeastern Nigeria’s war-torn Borno State, where at least 500,000 people are in urgent need of food, medical care, water, and shelter, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) warned today, calling for a major aid response.

July 19, 2016

Durban, South Africa—Global HIV/AIDS leaders at the International AIDS Conference in Durban must develop and implement an action plan to address the critical lack of access to HIV treatment in countries in West and Central Africa where coverage remains below 30 percent, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) Tuesday.

June 09, 2016

UN governments adopted a Political Declaration on Ending AIDS during the UN’s High-Level Meeting on Ending AIDS in New York on June 8, 2016, in which governments have committed to reaching 30 million people with HIV treatment by 2020.

Pages